Afb Antibiotic Sensitivity 10 Drugs Panel

9,000.00

The AFB Antibiotic Sensitivity – 10 Drugs Panel test is a comprehensive laboratory test used to determine the sensitivity or resistance of Mycobacterium tuberculosis bacteria (which cause tuberculosis) to a panel of ten anti-tuberculosis drugs. This panel typically includes both first-line and second-line anti-TB medications, such as:
• Isoniazid (INH)
• Rifampicin (RIF)
• Ethambutol (EMB)
• Pyrazinamide (PZA)
• Streptomycin (STR)
• Kanamycin (KAN) or Amikacin (AMK)
• Levofloxacin (LFX) or Ofloxacin (OFX)
• Ethionamide (ETH)
• Capreomycin (CAP)
• Cycloserine or Clofazimine (depending on lab protocols)
In the test, Mycobacterium tuberculosis isolated from patient samples is cultured and exposed to these antibiotics to identify which drugs effectively inhibit bacterial growth.

Enquiry Here

    Description

    Why It’s Done:

    • To identify the most effective drugs to treat a patient’s tuberculosis infection.
    • To detect drug resistance patterns, including multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB).
    • To assist healthcare providers in tailoring a personalized and effective treatment regimen.
    • To prevent ineffective treatments, reduce treatment failure, and help control the spread of resistant TB strains.

    Preparation:

    • No special preparation is required from the patient.
    • Clinical specimens (e.g., sputum, pleural fluid, tissue biopsy) must be collected in sterile containers and sent promptly to the laboratory.
    • Inform your healthcare provider if you are currently on anti-TB medications or other antibiotics.
    • Because this test relies on bacterial culture, results may take several weeks to be available.